ESTIMATES OF CARDIOVASCULAR RISK REDUCTION WITH NIACIN EXTENDED-RELEASE AND SIMVASTATIN IN MIXED DYSLIPIDEMIA

被引：0
作者：
Insull, W. [1 ]
Jiang, P. [2 ]
Tian, M. [2 ]
Thakkar, R. [2 ]
Padley, R. [2 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Abbott, Abbott Pk, IL USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
[31]   Extended-release niacin and laropiprant in the management of dyslipidemias [J].
Farnier, Michel .
CLINICAL LIPIDOLOGY, 2010, 5 (06) :783-791
[32]   Extended-Release Niacin (Nicotinic Acid)/Laropiprant [J].
Caroline M. Perry .
Drugs, 2009, 69 :1665-1679
[33]   Use of extended-release niacin in clinical practice [J].
Suryadevara, Ramya S. ;
Karas, Richard H. ;
Kuvin, Jeffrey T. .
FUTURE LIPIDOLOGY, 2008, 3 (01) :9-16
[34]   Extended-release niacin raises adiponectin and leptin [J].
Westphal, Sabine ;
Borucki, Katrin ;
Taneva, Elena ;
Makarova, Ruma ;
Luley, Claus .
ATHEROSCLEROSIS, 2007, 193 (02) :361-365
[35]   Safety and tolerability of extended-release niacin with laropiprant [J].
Yadav, Rahul ;
Kwok, See ;
Ammori, Basil J. ;
Issa, Basil ;
Soran, Handrean .
EXPERT OPINION ON DRUG SAFETY, 2012, 11 (01) :151-159
[36]   Extended-Release Niacin (Nicotinic Acid)/Laropiprant [J].
Perry, Caroline M. .
DRUGS, 2009, 69 (12) :1665-1679
[37]   Tredaptive((R)) : extended-release niacin with laropiprant [J].
van Schoor, Jacky .
SA PHARMACEUTICAL JOURNAL, 2012, 79 (09) :52-53
[38]   CARDIOVASCULAR EVENT REDUCTION AFTER TREATMENT WITH SIMVASTATIN PLUS NIACIN EXTENDED-RELEASE COMBINATION THERAPY VERSUS GENERIC SIMVASTATIN THERAPY FROM A MANAGED CARE ORGANIZATION'S PERSPECTIVE IN THE UNITED STATES [J].
Balu, S. ;
Quimbo, R. A. ;
Simko, R. J. ;
Cziraky, M. J. .
VALUE IN HEALTH, 2009, 12 (07) :A313-A313
[39]   Modeled achievement of optimal lipid values and associated cardiovascular event rates with extended-release niacin/simvastatin, ezetimibe/simvastatin, and individual agents in a managed care population [J].
Charland, S. L. ;
Quimbo, R. ;
Cziraky, M. J. ;
Weathermon, R. A. ;
Stanek, E. J. .
VALUE IN HEALTH, 2007, 10 (03) :A56-A56
[40]   Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia [J].
Farnier, Michel ;
Chen, Erluo ;
Johnson-Levonas, Amy O. ;
Sisk, Christine McCrary ;
Mitchel, Yale B. .
VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 :279-290
12345